sixth Annual Inmedix Charity Golf Tournament takes the Inmedix complete to almost $90,000.
NORMANDY PARK, WA, USA, September 16, 2022 /EINPresswire.com/ — Seattle-based biotech/medtech Inmedix, Inc. continued its effort to support kids with arthritis at its sixth annual Inmedix charity golf event at the Golf Club at Newcastle on Monday, August 29, 2022. Today, it introduced a remaining tally of $19,405 raised. After these six occasions, the corporate has offered almost $90,000 to support analysis and different urgent wants at the Pediatric Rheumatology division of the University of Washington at Seattle Children’s Hospital.
Inmedix is creating two essential medical advances: cloud-based scientific diagnostics and the idea of immuno-autonomics – the interface between immune operate and stress, managed throughout the mind by the autonomic nervous system (ANS). Fight-or-flight stress can drive autoimmune illness to extra and contribute to therapy resistance (1,2). With its CloudHRV™ diagnostic in improvement, Inmedix seeks to quantify ANS stress state at FDA regulatory requirements.
“This event has become a tradition,” stated Andrew J. Holman, MD, native rheumatologist, Inmedix CEO and Co-founder, and Clinical Associate Professor of Medicine at the University of Washington. “It continues to be an annual highlight for all of us at Inmedix. Most do not realize that children can suffer from autoimmune diseases and arthritis. Thankfully, our region is blessed with an exceptional and dedicated team at Seattle Children’s Hospital to address these needs and Inmedix is committed to supporting these remarkable medical professionals, the kids, and their families.”
References
1. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve – an integrative interface
between two supersystems: the mind and the immune system. Pharmacol Rev 2000;52:595-
638.
2. Taylor PC, Holman A J. Rheumatoid arthritis and the emergence of immuno-autonomics.
Rheumatology (Oxford). 2019 Dec 1;58(12):2079-2080. doi: 10.1093/rheumatology/kez216. PMID:31177267.
About Inmedix, Inc. and its subsidiary, Inmedix UK, Ltd.
Seattle-based biotech/medtech Inmedix, Inc. and its subsidiary Inmedix UK, Ltd., are dedicated to participating in world class analysis to uncover modern options for urgent healthcare wants associated to the affect of stress, modulated throughout the mind by the autonomic nervous system (ANS). The Inmedix CloudHRV™ system is main the event of coronary heart price variability (HRV) as a probably informative diagnostic, therapeutic, digital well being, and well being financial device. ANS profile could be the most neglected factor of customized, precision medication. Beginning with rheumatoid arthritis (RA), psoriatic arthritis (PsA), systemic lupus erythematosus (SLE) and ankylosing spondylitis (AS) in adults, the corporate hopes to perceive and validate the function of stress biology in immunology.
NOTICE:
This press launch comprises sure forward-looking statements, together with with out limitation statements concerning Inmedix’s plans for preclinical research and product capabilities. You are cautioned that such forward-looking statements are usually not ensures of future efficiency and contain dangers and uncertainties inherent in Inmedix’s business which may considerably have an effect on anticipated outcomes, together with with out limitation, progress of improvement, scientific testing and regulatory approval, developments in uncooked materials and personnel prices, and legislative, fiscal, and different regulatory measures. All forward-looking statements are certified of their entirety by this cautionary assertion, and Inmedix undertakes no obligation to revise or replace any forward-looking assertion to mirror occasions or circumstances after the issuance of this press launch. This is just not a proposal to promote or a proposal to buy securities.
Andrew Holman
Inmedix Inc.
+1 206-412-5347
electronic mail us right here
